Evidence map›Paper›PMID 31546915›Full record

ArticleMicroorganisms2019

Characterization of CRISPR-Cas Systems in

Maria Scrascia, Pietro D'Addabbo, Roberta Roberto, Francesco Porcelli, Marta Oliva, Carla Calia, Anna Maria Dionisi, Carlo Pazzani

Open access · goldAbstract read
In one paragraph

Article in Microorganisms, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. A Possible Outbreak byInternational journal of environmental research and public health · 2021
    Article
  6. Review
  7. Efficient Genome Editing inMicroorganisms · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Maria ScrasciaDepartment of Biology, University of Bari Aldo Moro, 70124 Bari, Italy. maria.scrascia@uniba.it.ORCID 0000-0003-3351-5273
Pietro D'AddabboDepartment of Biology, University of Bari Aldo Moro, 70124 Bari, Italy. pietro.daddabbo@uniba.it.ORCID 0000-0003-3325-4931
Roberta RobertoDepartment of Plants, Food, and Soil Sciences, University of Bari Aldo Moro, 70124 Bari, Italy. roberta.roberto@uniba.it.
Francesco PorcelliDepartment of Plants, Food, and Soil Sciences, University of Bari Aldo Moro, 70124 Bari, Italy. francesco.porcelli@uniba.it.ORCID 0000-0001-5620-7826
Marta OlivaDepartment of Biology, University of Bari Aldo Moro, 70124 Bari, Italy. marta.oliva@uniba.it.
Carla CaliaDepartment of Biology, University of Bari Aldo Moro, 70124 Bari, Italy. carla.calia@virgilio.it.
Anna Maria DionisiDepartment of Infectious diseases, Istituto Superiore di Sanità, 00161 Rome, Italy. annamaria.dionisi@iss.it.
Carlo PazzaniDepartment of Biology, University of Bari Aldo Moro, 70124 Bari, Italy. carlo.pazzani@uniba.it.ORCID 0000-0003-0414-2965
University of Bari Aldo Moro · ITIstituto Superiore di Sanità · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The CRISPR-Cas adaptive immune system has been attracting increasing scientific interest for biological functions and biotechnological applications. Data on the

Indexed as

CRISPR-Cas systemsRhynchophorus ferrugineusSerratia marcescenssubtype I-Esubtype I-Fsymbiont

Identifiers

PMID31546915
PMCPMC6780938
OpenAlexW2974396769

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.